144 related articles for article (PubMed ID: 31841869)
41. Species extrapolation of life-stage physiologically-based pharmacokinetic (PBPK) models to investigate the developmental toxicology of ethanol using in vitro to in vivo (IVIVE) methods.
Martin SA; McLanahan ED; Bushnell PJ; Hunter ES; El-Masri H
Toxicol Sci; 2015 Feb; 143(2):512-35. PubMed ID: 25410581
[TBL] [Abstract][Full Text] [Related]
42. Prediction of the pharmacokinetics and tissue distribution of levofloxacin in humans based on an extrapolated PBPK model.
Zhu L; Zhang Y; Yang J; Wang Y; Zhang J; Zhao Y; Dong W
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):395-402. PubMed ID: 25753830
[TBL] [Abstract][Full Text] [Related]
43. Physiologically based pharmacokinetic (PBPK) modeling of disposition of epiroprim in humans.
Luttringer O; Theil FP; Poulin P; Schmitt-Hoffmann AH; Guentert TW; Lavé T
J Pharm Sci; 2003 Oct; 92(10):1990-2007. PubMed ID: 14502539
[TBL] [Abstract][Full Text] [Related]
44. Application of PBPK modeling in support of the derivation of toxicity reference values for 1,1,1-trichloroethane.
Lu Y; Rieth S; Lohitnavy M; Dennison J; El-Masri H; Barton HA; Bruckner J; Yang RS
Regul Toxicol Pharmacol; 2008 Mar; 50(2):249-60. PubMed ID: 18226845
[TBL] [Abstract][Full Text] [Related]
45. The use of PBPK modeling across the pediatric age range using propofol as a case.
Michelet R; Van Bocxlaer J; Allegaert K; Vermeulen A
J Pharmacokinet Pharmacodyn; 2018 Dec; 45(6):765-785. PubMed ID: 30298439
[TBL] [Abstract][Full Text] [Related]
46. A novel amphibian tier 2 testing protocol: a 30-week exposure of Xenopus tropicalis to the antiandrogen flutamide.
Knechtges PL; Sprando RL; Porter KL; Brennan LM; Miller MF; Kumsher DM; Dennis WE; Brown CC; Clegg ED
Environ Toxicol Chem; 2007 Mar; 26(3):555-64. PubMed ID: 17373522
[TBL] [Abstract][Full Text] [Related]
47. Development of a screening approach to interpret human biomonitoring data on volatile organic compounds: reverse dosimetry on biomonitoring data for trichloroethylene.
Liao KH; Tan YM; Clewell HJ
Risk Anal; 2007 Oct; 27(5):1223-36. PubMed ID: 18076492
[TBL] [Abstract][Full Text] [Related]
48. Plasma and Hepatic Concentrations of Chemicals after Virtual Oral Administrations Extrapolated Using Rat Plasma Data and Simple Physiologically Based Pharmacokinetic Models.
Kamiya Y; Otsuka S; Miura T; Takaku H; Yamada R; Nakazato M; Nakamura H; Mizuno S; Shono F; Funatsu K; Yamazaki H
Chem Res Toxicol; 2019 Jan; 32(1):211-218. PubMed ID: 30511563
[TBL] [Abstract][Full Text] [Related]
49. An integrated QSPR-PBPK modelling approach for in vitro-in vivo extrapolation of pharmacokinetics in rats.
Kamgang E; Peyret T; Krishnan K
SAR QSAR Environ Res; 2008; 19(7-8):669-80. PubMed ID: 19061083
[TBL] [Abstract][Full Text] [Related]
50. Determination of a site-specific reference dose for methylmercury for fish-eating populations.
Shipp AM; Gentry PR; Lawrence G; Van Landingham C; Covington T; Clewell HJ; Gribben K; Crump K
Toxicol Ind Health; 2000 Nov; 16(9-10):335-438. PubMed ID: 11762928
[TBL] [Abstract][Full Text] [Related]
51. A systematic evaluation of the use of physiologically based pharmacokinetic modeling for cross-species extrapolation.
Thiel C; Schneckener S; Krauss M; Ghallab A; Hofmann U; Kanacher T; Zellmer S; Gebhardt R; Hengstler JG; Kuepfer L
J Pharm Sci; 2015 Jan; 104(1):191-206. PubMed ID: 25393841
[TBL] [Abstract][Full Text] [Related]
52. Development of an integrated multi-species and multi-dose route PBPK model for volatile methyl siloxanes - D4 and D5.
McMullin TS; Yang Y; Campbell J; Clewell HJ; Plotzke K; Andersen ME
Regul Toxicol Pharmacol; 2016 Feb; 74 Suppl():S1-13. PubMed ID: 26724268
[TBL] [Abstract][Full Text] [Related]
53. Sex-specific risk assessment of PFHxS using a physiologically based pharmacokinetic model.
Kim SJ; Shin H; Lee YB; Cho HY
Arch Toxicol; 2018 Mar; 92(3):1113-1131. PubMed ID: 29143853
[TBL] [Abstract][Full Text] [Related]
54. Feasibility and potential gains of enhancing the subacute rat study protocol (OECD test guideline no. 407) by additional parameters selected to determine endocrine modulation. A pre-validation study to determine endocrine-mediated effects of the antiandrogenic drug flutamide.
Andrews P; Freyberger A; Hartmann E; Eiben R; Loof I; Schmidt U; Temerowski M; Becka M
Arch Toxicol; 2001 Apr; 75(2):65-73. PubMed ID: 11354908
[TBL] [Abstract][Full Text] [Related]
55. Application of a hybrid CFD-PBPK nasal dosimetry model in an inhalation risk assessment: an example with acrylic acid.
Andersen M; Sarangapani R; Gentry R; Clewell H; Covington T; Frederick CB
Toxicol Sci; 2000 Oct; 57(2):312-25. PubMed ID: 11006361
[TBL] [Abstract][Full Text] [Related]
56. An introduction to physiologically-based pharmacokinetic models.
Upton RN; Foster DJ; Abuhelwa AY
Paediatr Anaesth; 2016 Nov; 26(11):1036-1046. PubMed ID: 27550716
[TBL] [Abstract][Full Text] [Related]
57. Plasma concentrations of melengestrol acetate in humans extrapolated from the pharmacokinetics established in in vivo experiments with rats and chimeric mice with humanized liver and physiologically based pharmacokinetic modeling.
Tsukada A; Suemizu H; Murayama N; Takano R; Shimizu M; Nakamura M; Yamazaki H
Regul Toxicol Pharmacol; 2013 Apr; 65(3):316-24. PubMed ID: 23395687
[TBL] [Abstract][Full Text] [Related]
58. Model-Based Analysis of Biopharmaceutic Experiments To Improve Mechanistic Oral Absorption Modeling: An Integrated in Vitro in Vivo Extrapolation Perspective Using Ketoconazole as a Model Drug.
Pathak SM; Ruff A; Kostewicz ES; Patel N; Turner DB; Jamei M
Mol Pharm; 2017 Dec; 14(12):4305-4320. PubMed ID: 28771009
[TBL] [Abstract][Full Text] [Related]
59. Physiologically based pharmacokinetic modeling of POPs in Greenlanders.
Sonne C; Gustavson K; Rigét FF; Dietz R; Krüger T; Bonefeld-Jørgensen EC
Environ Int; 2014 Mar; 64():91-7. PubMed ID: 24382481
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of the model anti-androgen flutamide for assessing the mechanistic basis of responses to an androgen in the fathead minnow (Pimephales promelas).
Ankley GT; Defoe DL; Kahl MD; Jensen KM; Makynen EA; Miracle A; Hartig P; Gray LE; Cardon M; Wilson V
Environ Sci Technol; 2004 Dec; 38(23):6322-7. PubMed ID: 15597888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
